Indication and Usage: LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection. The PI-experienced–patient study was not large enough to reach a definitive conclusion that LEXIVA/ritonavir and lopinavir/ritonavir are clinically equivalent. Once-daily administration of LEXIVA plus ritonavir is not recommended for PI-experienced patients or any pediatric patients. LEXIVA does not cure HIV or prevent passing HIV to others.
Important Safety Information: You should not take LEXIVA if you have had an allergic reaction to LEXIVA or AGENERASE® (amprenavir). Tell your healthcare provider if you have liver or kidney problems, have diabetes or hemophilia, are allergic to sulfa medicines, or are pregnant, planning to become pregnant, or breastfeeding. CONTINUED BELOW
LEXIVA is a protease inhibitor that treats HIV. Its benefits include lowering your viral load. As with all medicines, LEXIVA also has some side effects. Knowing both the benefits and risks can help you plan your treatment with your doctor and your support system.
Unlike other HIV medicines of its kind, LEXIVA does not cause your skin or eyes to turn yellow. LEXIVA does not cause your body to make more bilirubin, a liver enzyme. An excess of bilirubin can cause yellowing of the skin and eyes.
The most common side effects in clinical studies of LEXIVA were diarrhea, headache, nausea, rash, and vomiting. In most cases, these side effects did not cause people to stop taking their medicine. Other important side effects occurring in some patients included high blood sugar, diabetes or worsening of diabetes, bleeding in hemophiliacs, changes in body fat, and skin rashes.
Coping with side effects is part of your treatment, too. Your healthcare provider can help. Be sure to let your doctor know what side effects you're having. For more ways to talk to your doctor, see the Doctor Discussion Guide.
*Individual experiences may vary. By prescription only.
Talk to your doctor to see if LEXIVA is right for you.
Please see the full Prescribing Information for LEXIVA
LEXIVA is indicated in combination with other antiretroviral agents for the treatment of HIV infection.
LEXIVA does not cure HIV or prevent passing HIV to others.